DK1047409T3 - TTS indeholdende en antioxidant - Google Patents

TTS indeholdende en antioxidant

Info

Publication number
DK1047409T3
DK1047409T3 DK99902525T DK99902525T DK1047409T3 DK 1047409 T3 DK1047409 T3 DK 1047409T3 DK 99902525 T DK99902525 T DK 99902525T DK 99902525 T DK99902525 T DK 99902525T DK 1047409 T3 DK1047409 T3 DK 1047409T3
Authority
DK
Denmark
Prior art keywords
antioxidant
ethyl
tts containing
tts
carbamate
Prior art date
Application number
DK99902525T
Other languages
English (en)
Inventor
Bodo Asmussen
Michael Horstmann
Kai Koepke
Harry Tiemessen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1047409(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1047409T3 publication Critical patent/DK1047409T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99902525T 1998-01-12 1999-01-08 TTS indeholdende en antioxidant DK1047409T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (1)

Publication Number Publication Date
DK1047409T3 true DK1047409T3 (da) 2002-12-30

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902525T DK1047409T3 (da) 1998-01-12 1999-01-08 TTS indeholdende en antioxidant

Country Status (25)

Country Link
US (1) US6335031B1 (da)
EP (1) EP1047409B1 (da)
KR (1) KR100569051B1 (da)
CN (1) CN1129427C (da)
AT (1) ATE223711T1 (da)
AU (1) AU745661B2 (da)
BR (1) BR9906920A (da)
CA (1) CA2315784C (da)
CZ (1) CZ300598B6 (da)
DE (1) DE69902875T2 (da)
DK (1) DK1047409T3 (da)
ES (1) ES2184408T3 (da)
GB (1) GB9800526D0 (da)
HU (1) HU227159B1 (da)
ID (1) ID27503A (da)
IL (1) IL137100A (da)
MX (1) MXPA00006438A (da)
NO (1) NO328390B1 (da)
NZ (1) NZ505650A (da)
PL (1) PL201328B1 (da)
PT (1) PT1047409E (da)
RU (1) RU2219926C2 (da)
SK (1) SK284622B6 (da)
TR (2) TR200101021T2 (da)
WO (1) WO1999034782A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914251A (pt) 1998-10-01 2001-06-19 Novartis Ag Formulações orais de liberação sustentada
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
EP1233763B1 (de) * 1999-11-29 2003-07-30 LTS Lohmann Therapie-Systeme AG Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
EP2309985B1 (en) * 2008-07-28 2018-03-14 Takeda Pharmaceutical Company Limited Pharmaceutical composition
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2670227T3 (es) 2009-12-22 2018-05-29 Luye Pharma Ag Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2012012417A1 (en) 2010-07-21 2012-01-26 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
DK2468274T3 (da) 2010-12-14 2015-08-31 Acino Ag Transdermalt terapeutisk system til administration af et aktivstof
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
BR112013029945A2 (pt) 2011-05-20 2017-01-31 Sk Chemicals Co Ltd emplastro contendo rivastigmina
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
US10758494B2 (en) 2012-06-12 2020-09-01 KM Transderm Ltd. Rivastigmine-containing adhesive patch
CA2883930A1 (en) * 2012-09-03 2014-03-06 Nipro Patch Co., Ltd. Adhesive skin patch
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (ja) 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
JPWO2015174502A1 (ja) 2014-05-15 2017-05-25 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
CN115087445A (zh) * 2020-02-19 2022-09-20 住友制药株式会社 经皮吸收制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP0952826B1 (en) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
PL201328B1 (pl) 2009-03-31
CA2315784A1 (en) 1999-07-15
HUP0004300A3 (en) 2003-05-28
MXPA00006438A (es) 2003-07-21
DE69902875D1 (de) 2002-10-17
JP3820103B2 (ja) 2006-09-13
SK284622B6 (sk) 2005-08-04
ATE223711T1 (de) 2002-09-15
WO1999034782A1 (en) 1999-07-15
JP2002500178A (ja) 2002-01-08
GB9800526D0 (en) 1998-03-11
CA2315784C (en) 2006-06-27
NO20003472D0 (no) 2000-07-05
CN1288375A (zh) 2001-03-21
SK10532000A3 (sk) 2000-11-07
TR200001688T2 (tr) 2000-11-21
CZ20002557A3 (cs) 2000-10-11
RU2219926C2 (ru) 2003-12-27
EP1047409A1 (en) 2000-11-02
IL137100A (en) 2004-12-15
ES2184408T3 (es) 2003-04-01
ID27503A (id) 2001-04-12
HU227159B1 (en) 2010-09-28
US6335031B1 (en) 2002-01-01
NZ505650A (en) 2002-10-25
CN1129427C (zh) 2003-12-03
AU745661B2 (en) 2002-03-28
CZ300598B6 (cs) 2009-06-24
BR9906920A (pt) 2000-10-10
NO20003472L (no) 2000-08-07
KR20010033072A (ko) 2001-04-25
NO328390B1 (no) 2010-02-08
HK1034036A1 (en) 2001-10-12
TR200101021T2 (tr) 2002-06-21
PT1047409E (pt) 2002-12-31
PL341347A1 (en) 2001-04-09
HUP0004300A2 (hu) 2001-05-28
AU2278599A (en) 1999-07-26
DE69902875T2 (de) 2003-05-22
EP1047409B1 (en) 2002-09-11
KR100569051B1 (ko) 2006-04-10
IL137100A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
DK1047409T3 (da) TTS indeholdende en antioxidant
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
BR0107869A (pt) Composições farmacêuticas eletrogiradas
TR200502189T1 (tr) Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
ATE288256T1 (de) Dermale zusammensetzungen
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
EP1478406A4 (en) COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS AND OTHER MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
ATE359066T1 (de) Pflaster mit 4-biphenylessigsäure
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase